Lactitol

CHEMBL1661 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
344.3 g/mol
LogP
-5.2
Phase
4

This sugar alcohol that is poorly absorbed from the gut is used as a laxative for constipation and, at higher doses, to treat a serious complication of liver disease called hepatic encephalopathy by reducing ammonia-producing bacteria in the colon. Gut bacteria ferment it to produce acids that trap ammonia and promote bowel movements.

Molekularmasse

344,3100 g/mol

LogP

-5,20

TPSA

201,00 Ų

Lipinski-Regel der Fünf

Nicht bestanden

Therapeutische Bereiche

Wirkmechanismus

Increases water content in the intestinal lumen through osmotic or stimulant mechanisms, promoting bowel motility and facilitating defecation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanismus

Increases water content in the intestinal lumen through osmotic or stimulant mechanisms, promoting bowel motility and facilitating defecation.

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)CO

InChI

InChI=1S/C12H24O11/c13-1-4(16)7(18)11(5(17)2-14)23-12-10(21)9(20)8(19)6(3-15)22-12/h4-21H,1-3H2/t4-,5+,6+,7+,8-,9-,10+,11+,12-/m0/s1

Molecular Formula

C12H24O11

HBD / HBA

9 / 11

Rotierbare Bindungen

8

Schwere Atome

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

This sugar alcohol that is poorly absorbed from the gut is used as a laxative for constipation and, at higher doses, to treat a serious complication of liver disease called hepatic encephalopathy by reducing ammonia-producing bacteria in the colon. Gut bacteria ferment it to produce acids that trap ammonia and promote bowel movements.

Increases water content in the intestinal lumen through osmotic or stimulant mechanisms, promoting bowel motility and facilitating defecation.

Yes, Lactitol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1661. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 157355. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.